reference/8250041

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8250041

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase III\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	210
issn	2215-0366
issueIdentifier	3
pageRange	199-210
publicationName	The lancet. Psychiatry
startingPage	199
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_3c3cd0e475b3e8b6050d12ce5ac047ca http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_90caa73e5538060f820f129680c611e0
bibliographicCitation	Jacob S, Veenstra-VanderWeele J, Murphy D, McCracken J, Smith J, Sanders K, Meyenberg C, Wiese T, Deol-Bhullar G, Wandel C, Ashford E, Anagnostou E. Efficacy and safety of balovaptan for socialisation and communication difficulties in autistic adults in North America and Europe: a phase 3, randomised, placebo-controlled trial. Lancet Psychiatry. 2022 Mar;9(3):199–210. doi: 10.1016/s2215-0366(21)00429-6. PMID: 35151410.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_89aa38ff49e40a0ba373deb344c7b413 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6f4cc39dedf2e513992aa66a760859f6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3df20d127d42beb71aa48f9a48ab84fa http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0154ad75d26c02f9b6242c22cb20001a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5bc2d36a2cd8a582c6f191ff7f8e782c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8b3d0eb812a038aa350f9590d3c67324 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ef99ed23ff8b733083ece55c0ebeeb2e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_80ba1c98662ec910ce051938e20903b3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_43d7e4c12d4dc81520b610b15cab349c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c09780412ef3f14b47f470f5668c86f0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3c7e1e5eae9f85e738e7cf2b7a2e1231 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3cc4640c6464a338f7c33389b0fe4b84
date	202203
identifier	https://doi.org/10.1016/s2215-0366%2821%2900429-6 https://pubmed.ncbi.nlm.nih.gov/35151410
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/42935 https://portal.issn.org/resource/ISSN/2215-0366
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Efficacy and safety of balovaptan for socialisation and communication difficulties in autistic adults in North America and Europe: a phase 3, randomised, placebo-controlled trial
discusses	http://id.nlm.nih.gov/mesh/M0021911 http://id.nlm.nih.gov/mesh/M000735997 http://id.nlm.nih.gov/mesh/M0018233 http://id.nlm.nih.gov/mesh/M0002356 http://id.nlm.nih.gov/mesh/M0587243
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000067877Q000188 http://id.nlm.nih.gov/mesh/D003147Q000188 http://id.nlm.nih.gov/mesh/D014230Q000008 http://id.nlm.nih.gov/mesh/D011725Q000008 http://id.nlm.nih.gov/mesh/D001569Q000008 http://id.nlm.nih.gov/mesh/D065092Q000008
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000067877Q000150 http://id.nlm.nih.gov/mesh/D003147Q000209 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D001569Q000009 http://id.nlm.nih.gov/mesh/D014230Q000009 http://id.nlm.nih.gov/mesh/D065092Q000009 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D011725Q000009
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9893 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7000 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9013 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8756 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8177 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8592 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9040 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7299 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7483 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6499 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7507 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46200932 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6515 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9083

Showing number of triples: 1 to 68 of 68.